Exome and whole-genome analyses powered by next-generation sequencing (NGS) have become invaluable tools in identifying causal mutations responsible for Mendelian disorders. Given that individual exomes contain several thousand single nucleotide variants and insertions/deletions, it remains a challenge to analyze large numbers of variants from multiple exomes to identify causal alleles associated with inherited conditions. To this end, we have developed user-friendly software that analyzes variant calls from multiple individuals to facilitate identification of causal mutations. The software, termed exomeSuite, filters for putative causative variants of monogenic diseases inherited in one of three forms: dominant, recessive caused by a homoz...
Spontaneously arising mouse mutations have served as the foundation for understanding gene function ...
Motivation: Next-Generation Sequencing (NGS) and exome-capture technologies are currently revolution...
International audienceBackgroundWhole exome sequencing (WES) has become the strategy of choice to id...
AbstractExome and whole-genome analyses powered by next-generation sequencing (NGS) have become inva...
Mendelian disorders are mostly caused by single mutations in the DNA sequence of a gene, leading to ...
Recent breakthroughs in exome-sequencing technology have made possible the identification of many ca...
Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identif...
MOTIVATION: Next-generation sequencing and exome-capture technologies are currently revolutionizing ...
New sequencing technology has enabled the identification of thousands of single nucleotide polymorph...
Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identif...
Computational analyses of human patient exomes aim to filter out as many nonpathogenic genetic varia...
A significant challenge facing clinical translation of exome sequencing is meaningful and efficient ...
Next-generation sequencing has catapulted healthcare into a revolutionary genomics era. One such tec...
The identification of disease-causing variants in autosomal dominant diseases using exome-sequencing...
Spontaneously arising mouse mutations have served as the foundation for understanding gene function ...
Spontaneously arising mouse mutations have served as the foundation for understanding gene function ...
Motivation: Next-Generation Sequencing (NGS) and exome-capture technologies are currently revolution...
International audienceBackgroundWhole exome sequencing (WES) has become the strategy of choice to id...
AbstractExome and whole-genome analyses powered by next-generation sequencing (NGS) have become inva...
Mendelian disorders are mostly caused by single mutations in the DNA sequence of a gene, leading to ...
Recent breakthroughs in exome-sequencing technology have made possible the identification of many ca...
Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identif...
MOTIVATION: Next-generation sequencing and exome-capture technologies are currently revolutionizing ...
New sequencing technology has enabled the identification of thousands of single nucleotide polymorph...
Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identif...
Computational analyses of human patient exomes aim to filter out as many nonpathogenic genetic varia...
A significant challenge facing clinical translation of exome sequencing is meaningful and efficient ...
Next-generation sequencing has catapulted healthcare into a revolutionary genomics era. One such tec...
The identification of disease-causing variants in autosomal dominant diseases using exome-sequencing...
Spontaneously arising mouse mutations have served as the foundation for understanding gene function ...
Spontaneously arising mouse mutations have served as the foundation for understanding gene function ...
Motivation: Next-Generation Sequencing (NGS) and exome-capture technologies are currently revolution...
International audienceBackgroundWhole exome sequencing (WES) has become the strategy of choice to id...